NFAT1-based Therapeutics for Joint Diseases Patent

The European Patent Office has published patent application EP2026030377A1 concerning NFAT1-based therapeutics for joint diseases. The publication date is March 18, 2026, and the application includes various IPC classifications related to pharmaceutical compositions and viral vectors.

EPO Patent Application: Myeloid Derived Suppressor Cells for Transplantation Tolerance

The European Patent Office has published a patent application (EP2026030538A1) concerning methods for using CD84+/MERTK+ myeloid derived suppressor cells for transplantation tolerance. The application was published on March 18, 2026, and lists various European states as designated for patent protection.

EPO Patent Application EP2026030528A1 for Activated Hepatocyte Growth Factor

The European Patent Office (EPO) has published patent application EP2026030528A1 concerning activated hepatocyte growth factor. The publication date is March 18, 2026, and the inventors have not yet been designated.

EPO Patent Publication: Engineered Producer Cell

The European Patent Office (EPO) has published a patent application (EP2026030520A1) related to engineered producer cells and methods for their production and use. The publication date is March 18, 2026, and it covers multiple designated states within the European Union.

EPO Patent Publication: Gene Insertion and Expression Methods

The European Patent Office has published a patent application (EP2026030518A1) detailing methods for improved gene insertion and expression in cell lines. The publication date is March 18, 2026, and it covers various IPC classifications related to genetic engineering and cell culture.

EPO Patent Application: Plant Autophagy Regulation for Protein Accumulation

The European Patent Office has published patent application EP2026030502A1 concerning the regulation of plant autophagy to enhance recombinant protein accumulation. The application details methods and compositions for improving protein production in plants, with a publication date of March 18, 2026.

African Swine Fever Virus Vaccine Compositions

The European Patent Office has published a patent application (EP2026030491A1) for African Swine Fever Virus vaccine compositions and methods of making and using them. The publication date is March 18, 2026. The inventors have not yet been designated.

Therapeutic Agent Delivery Methods via Ultrasound Patent Application

The European Patent Office has published patent application EP2026030486A1 concerning methods and compositions for delivering therapeutic agents via ultrasound. The publication date is March 18, 2026, and it covers various IPC classifications related to biotechnology and drug delivery.

EPO Patent Granted for Anti-Trop2 Antibody-Drug Conjugate Production

The European Patent Office has granted a patent (EP3424955B1) for a method of producing an anti-Trop2 antibody-drug conjugate. The patent was published on March 18, 2026, and covers production methods relevant to the pharmaceutical and biotechnology sectors.

EPO Patent Grant: Method for Specific Isolation of Nucleic Acids

The European Patent Office has granted patent EP3578654B1 for a method for the specific isolation of nucleic acids. This patent, effective March 18, 2026, covers innovations in biotechnology relevant to drug development and research.